血浆Fas配体水平与脓毒症严重程度及结局的关联
该前瞻性队列纳入188例危重症成人,其中58例(30.9%)脓毒症、84例(44.7%)脓毒性休克,用ELISA测血浆FasL和RIPK3。FasL水平按对照组、脓毒症组、脓毒性休克组顺序升高(趋势P<0.001)。在142例脓毒症患者中,FasL高于最佳截断值者器官功能障碍和脓毒性休克更常见,高FasL与低FasL组90天内死亡率差异显著(Log-rank P=0.013)。FasL第3天和第7天无显著变化,且与RIPK3无相关性。
要点
- 在188例危重症成人中,血浆FasL水平按对照组、脓毒症组、脓毒性休克组顺序升高(趋势P<0.001)。
- 在142例脓毒症患者中,FasL高于最佳截断值者器官功能障碍和脓毒性休克更常见。
- 高FasL与低FasL组90天内死亡率差异显著(Log-rank P=0.013)。
- FasL水平在第3天和第7天无显著变化。
- FasL水平与RIPK3水平无相关性。
适用人群与场景
- 前瞻性纳入的成人危重症患者,共188例,其中脓毒症58例(30.9%)、脓毒性休克84例(44.7%)。
诊断标准与关键阈值
- FasL预测28天死亡率的最佳截断值由Youden指数确定。
- 原文未提及脓毒症和脓毒性休克的诊断标准名称及具体界值。
处置流程与药物剂量
- 原文未提及
红旗征与不能漏的情况
- 原文未提及
研究设计与关键结果
- 研究类型为前瞻性队列,样本量188例,单中心或多中心未提及;人群为成人危重症患者。
- 血浆FasL水平按对照组、脓毒症组、脓毒性休克组顺序升高(趋势P<0.001)。
- 在142例脓毒症患者中,FasL高于最佳截断值者器官功能障碍和脓毒性休克更常见。
- 高FasL与低FasL组90天内死亡率差异显著(Log-rank P=0.013)。
- FasL水平在第3天和第7天无显著变化。
- FasL水平与RIPK3水平无相关性(线性回归)。
证据类型、等级与局限
- 证据类型为前瞻性队列研究。
- 局限:原文未明确说明研究设计细节(如单中心、盲法、样本量计算等),原文未提及。
对床旁实践的改变
- 血浆FasL水平可能有助于识别脓毒症患者中器官功能障碍和脓毒性休克风险更高、90天死亡率更高的亚组,但最佳截断值需参照原文Youden指数结果,原文未给出具体数值。
- FasL与RIPK3无相关性,提示FasL不能作为坏死性凋亡通路的替代标志物。
- 原文未提及基于FasL水平的治疗干预或流程改变。
指南或共识出处
- 原文未提及
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
INTRODUCTION: Levels of the apoptosis regulator Fas ligand (FasL) are associated with severity of sepsis, but its association with the mortality of sepsis and necroptosis, a regulated cell death mechanism, is not yet clear. We aimed to assess the association of FasL level with outcomes of sepsis and receptor interacting protein kinase-3 (RIPK3), an essential necroptosis mediator, for determining the relationship between FasL and necroptosis.
METHODS: Plasma FasL and RIPK3 levels were measured by ELISA from prospectively enrolled critically ill adult patients. The best cut-off level of FasL for 28-day mortality prediction was determined by Youden's index. The association between plasma levels of FasL and RIPK3 was assessed by a linear regression method.
RESULTS: Among 188 patients, 58 (30.9%) were diagnosed with sepsis and 84 (44.7%) with septic shock, respectively. Plasma levels of FasL increased in the group order of control, sepsis, and septic shock groups (P for trend < 0.001). For 142 patients with sepsis, organ dysfunction and septic shock were more prevalent in the group with plasma FasL levels that were higher than the best cut-off level. A significant difference in mortality between high and low FasL patients was observed up to 90 days (Log-rank P = 0.013). FasL levels did not significantly change over day 3 and day 7. FasL levels were not correlated with those of RIPK3.
CONCLUSIONS: The plasma level of FasL was associated with severity of sepsis and was predictive of mortality. However, it was not correlated with RIPK3 level.
参考来源
- Yoo H, Lee JY, Park J, et al. Association of Plasma Levels of Fas Ligand with Severity and Outcome of Sepsis. Shock. 2021. PMID: 33577245. doi:10.1097/SHK.0000000000001753
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。